Zadnjih godina, Srbija je doživjela povećan uvoz lijekova, a istovremeno i pad od 43,5% u proizvodnji domaćih proizvođača lijekova.
In recent years, Serbia has seen an increase in medicine imports and, at the same time, a 43.5% drop in production by domestic drug manufacturers.